Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
novartis
roche
4
×
san francisco top stories
boston blog main
boston top stories
clinical trials
national
new york top stories
san francisco blog main
amgen
biogen
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
diagnostics
drug prices
fda
gene therapy
immunotherapy
indiana blog main
indiana top stories
investing
medical devices
medicare
merck
new york blog main
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
What
patients
4
×
drug
bio
new
roundup
acquisitions
advantages
albert
analytics
approved
atrophy
bar
biggest
biofourmis
bourla
brings
ceo
company
crispr
daily
data
devices
digital
employs
evrysdi
expect
fda
friday
future
gamble
globally
green
hauls
help
home
imports
intended
lights
liquid
maker
Language
unset
unknown
Current search:
roche
×
patients
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
